- Home
- LGND
as of 12-31-2025 11:41am EST
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 3.9B | IPO Year: | 1992 |
| Target Price: | $239.33 | AVG Volume (30 days): | 206.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.49 | EPS Growth: | 0.76 |
| 52 Week Low/High: | $93.58 - $212.49 | Next Earning Date: | 11-06-2025 |
| Revenue: | $251,233,000 | Revenue Growth: | 64.83% |
| Revenue Growth (this year): | 52.87% | Revenue Growth (next year): | 6.07% |
AI-Powered LGND Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Compare LGND vs Leading Stocks
See how LGND stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "LGND Ligand Pharmaceuticals Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.